Loading…

Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study

Background Chronic hepatitis C (CHC) genotype 1b patients with high viral load are resistant to peginterferon (PEG-IFN) and ribavirin (RBV) combination therapy, especially older and female patients. Methods To elucidate the factors affecting early and sustained viral responses (EVR and SVR), 409 gen...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gastroenterology 2009-09, Vol.44 (9), p.952-963
Main Authors: Okanoue, Takeshi, Itoh, Yoshito, Hashimoto, Hiroaki, Yasui, Kohichiroh, Minami, Masahito, Takehara, Tetsuo, Tanaka, Eiji, Onji, Morikazu, Toyota, Joji, Chayama, Kazuaki, Yoshioka, Kentaro, Izumi, Namiki, Akuta, Norio, Kumada, Hiromitsu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c544t-6cf3132a0fee4c4a369bb5cda3ced49866f28b50d80ed5ec4d1fad3a3f4903093
cites cdi_FETCH-LOGICAL-c544t-6cf3132a0fee4c4a369bb5cda3ced49866f28b50d80ed5ec4d1fad3a3f4903093
container_end_page 963
container_issue 9
container_start_page 952
container_title Journal of gastroenterology
container_volume 44
creator Okanoue, Takeshi
Itoh, Yoshito
Hashimoto, Hiroaki
Yasui, Kohichiroh
Minami, Masahito
Takehara, Tetsuo
Tanaka, Eiji
Onji, Morikazu
Toyota, Joji
Chayama, Kazuaki
Yoshioka, Kentaro
Izumi, Namiki
Akuta, Norio
Kumada, Hiromitsu
description Background Chronic hepatitis C (CHC) genotype 1b patients with high viral load are resistant to peginterferon (PEG-IFN) and ribavirin (RBV) combination therapy, especially older and female patients. Methods To elucidate the factors affecting early and sustained viral responses (EVR and SVR), 409 genotype 1b patients CHC with high viral loads who had received 48 weeks of PEG-IFN/RBV therapy were enrolled. The amino acid (aa) sequences of the HCV core at positions 70 and 91 and of the interferon sensitivity determining region (ISDR) were analyzed. Host factors, viral factors, and treatment-related factors were subjected to multivariate analysis. Results Male gender, low HCV RNA load, high platelet count, two or more aa mutations of ISDR, and wild type of core aa 70 were independent predictive factors for SVR. In patients with over 80% adherences to both PEG-IFN and RBV, male gender, mild fibrosis stage, and wild type of core aa 70 were independent predictors for SVR. Conclusions Independent predictive factors for SVR were: no aa substitution at core aa 70, two or more aa mutations in the ISDR, low viral load, high values of platelet count, mild liver fibrosis and male gender.
doi_str_mv 10.1007/s00535-009-0087-x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21084030</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1862216151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c544t-6cf3132a0fee4c4a369bb5cda3ced49866f28b50d80ed5ec4d1fad3a3f4903093</originalsourceid><addsrcrecordid>eNp9kc2OFCEUhYnROO3oA7hR4sJdKRRQP-4mHX8zUZNx1uQ2XHqYVBUlUJPpV_CppVOdTOLCBSE5fOdw4RDykrN3nLH2fWJMCVUx1pfVtdX9I7Lhsiiqr-vHZMN6KSvOW3lGnqV0yxgXTHVPyRnvFW-Zajfkz8-I1pvs75DewbBgosFRGP0UKBhvacLfC05m1fMNUhMiUpgs_X6lLmjEvQ9Ton4qWknxEYYjFmE-UBcivcEZss8-0e0HCvQbzDBhQjouQ_aVwSljpCkv9vCcPHEwJHxx2s_J9aePv7Zfqssfn79uLy4ro6TMVWOc4KIG5hClkSCafrdTxoIwaGXfNY2ru51itmNoFRppuQMrQDjZM8F6cU7errlzDOVtKevRJ4PDUAYLS9I1Z50sZAHf_APehiVOZbbCtLx8sqwLxFfIxJBSRKfn6EeIB82ZPrak15Z0aUkfW9L3xfPqFLzsRrQPjlMtBahXIJWjaY_x4eb_pb5eTQ6Chn30SV9f1cfOedPxpm_FXyYvqCU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217159242</pqid></control><display><type>article</type><title>Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study</title><source>Springer Nature</source><creator>Okanoue, Takeshi ; Itoh, Yoshito ; Hashimoto, Hiroaki ; Yasui, Kohichiroh ; Minami, Masahito ; Takehara, Tetsuo ; Tanaka, Eiji ; Onji, Morikazu ; Toyota, Joji ; Chayama, Kazuaki ; Yoshioka, Kentaro ; Izumi, Namiki ; Akuta, Norio ; Kumada, Hiromitsu</creator><creatorcontrib>Okanoue, Takeshi ; Itoh, Yoshito ; Hashimoto, Hiroaki ; Yasui, Kohichiroh ; Minami, Masahito ; Takehara, Tetsuo ; Tanaka, Eiji ; Onji, Morikazu ; Toyota, Joji ; Chayama, Kazuaki ; Yoshioka, Kentaro ; Izumi, Namiki ; Akuta, Norio ; Kumada, Hiromitsu</creatorcontrib><description>Background Chronic hepatitis C (CHC) genotype 1b patients with high viral load are resistant to peginterferon (PEG-IFN) and ribavirin (RBV) combination therapy, especially older and female patients. Methods To elucidate the factors affecting early and sustained viral responses (EVR and SVR), 409 genotype 1b patients CHC with high viral loads who had received 48 weeks of PEG-IFN/RBV therapy were enrolled. The amino acid (aa) sequences of the HCV core at positions 70 and 91 and of the interferon sensitivity determining region (ISDR) were analyzed. Host factors, viral factors, and treatment-related factors were subjected to multivariate analysis. Results Male gender, low HCV RNA load, high platelet count, two or more aa mutations of ISDR, and wild type of core aa 70 were independent predictive factors for SVR. In patients with over 80% adherences to both PEG-IFN and RBV, male gender, mild fibrosis stage, and wild type of core aa 70 were independent predictors for SVR. Conclusions Independent predictive factors for SVR were: no aa substitution at core aa 70, two or more aa mutations in the ISDR, low viral load, high values of platelet count, mild liver fibrosis and male gender.</description><identifier>ISSN: 0944-1174</identifier><identifier>EISSN: 1435-5922</identifier><identifier>DOI: 10.1007/s00535-009-0087-x</identifier><identifier>PMID: 19517057</identifier><language>eng</language><publisher>Japan: Japan : Springer Japan</publisher><subject>Abdominal Surgery ; Adolescent ; Adult ; Aged ; Amino Acid Sequence ; Amino Acid Substitution ; Antiviral Agents - pharmacology ; Biliary Tract ; Colorectal Surgery ; Drug Resistance, Viral ; Drug Therapy, Combination ; Female ; Gastroenterology ; Genotype ; Hepacivirus - drug effects ; Hepacivirus - genetics ; Hepatitis C virus ; Hepatitis C, Chronic - drug therapy ; Hepatitis C, Chronic - genetics ; Hepatology ; Humans ; Interferon alpha-2 ; Interferon-alpha - pharmacology ; Japan ; Male ; Medication Adherence ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Multivariate Analysis ; Mutation ; Original Article—Liver ; Pancreas ; Polyethylene Glycols - pharmacology ; Recombinant Proteins ; Retrospective Studies ; Ribavirin - pharmacology ; Risk Factors ; Sex Factors ; Surgical Oncology ; Viral Load ; Viral Nonstructural Proteins - genetics ; Young Adult</subject><ispartof>Journal of gastroenterology, 2009-09, Vol.44 (9), p.952-963</ispartof><rights>Springer 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c544t-6cf3132a0fee4c4a369bb5cda3ced49866f28b50d80ed5ec4d1fad3a3f4903093</citedby><cites>FETCH-LOGICAL-c544t-6cf3132a0fee4c4a369bb5cda3ced49866f28b50d80ed5ec4d1fad3a3f4903093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19517057$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Okanoue, Takeshi</creatorcontrib><creatorcontrib>Itoh, Yoshito</creatorcontrib><creatorcontrib>Hashimoto, Hiroaki</creatorcontrib><creatorcontrib>Yasui, Kohichiroh</creatorcontrib><creatorcontrib>Minami, Masahito</creatorcontrib><creatorcontrib>Takehara, Tetsuo</creatorcontrib><creatorcontrib>Tanaka, Eiji</creatorcontrib><creatorcontrib>Onji, Morikazu</creatorcontrib><creatorcontrib>Toyota, Joji</creatorcontrib><creatorcontrib>Chayama, Kazuaki</creatorcontrib><creatorcontrib>Yoshioka, Kentaro</creatorcontrib><creatorcontrib>Izumi, Namiki</creatorcontrib><creatorcontrib>Akuta, Norio</creatorcontrib><creatorcontrib>Kumada, Hiromitsu</creatorcontrib><title>Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study</title><title>Journal of gastroenterology</title><addtitle>J Gastroenterol</addtitle><addtitle>J Gastroenterol</addtitle><description>Background Chronic hepatitis C (CHC) genotype 1b patients with high viral load are resistant to peginterferon (PEG-IFN) and ribavirin (RBV) combination therapy, especially older and female patients. Methods To elucidate the factors affecting early and sustained viral responses (EVR and SVR), 409 genotype 1b patients CHC with high viral loads who had received 48 weeks of PEG-IFN/RBV therapy were enrolled. The amino acid (aa) sequences of the HCV core at positions 70 and 91 and of the interferon sensitivity determining region (ISDR) were analyzed. Host factors, viral factors, and treatment-related factors were subjected to multivariate analysis. Results Male gender, low HCV RNA load, high platelet count, two or more aa mutations of ISDR, and wild type of core aa 70 were independent predictive factors for SVR. In patients with over 80% adherences to both PEG-IFN and RBV, male gender, mild fibrosis stage, and wild type of core aa 70 were independent predictors for SVR. Conclusions Independent predictive factors for SVR were: no aa substitution at core aa 70, two or more aa mutations in the ISDR, low viral load, high values of platelet count, mild liver fibrosis and male gender.</description><subject>Abdominal Surgery</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Amino Acid Sequence</subject><subject>Amino Acid Substitution</subject><subject>Antiviral Agents - pharmacology</subject><subject>Biliary Tract</subject><subject>Colorectal Surgery</subject><subject>Drug Resistance, Viral</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Gastroenterology</subject><subject>Genotype</subject><subject>Hepacivirus - drug effects</subject><subject>Hepacivirus - genetics</subject><subject>Hepatitis C virus</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Hepatitis C, Chronic - genetics</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Interferon alpha-2</subject><subject>Interferon-alpha - pharmacology</subject><subject>Japan</subject><subject>Male</subject><subject>Medication Adherence</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Mutation</subject><subject>Original Article—Liver</subject><subject>Pancreas</subject><subject>Polyethylene Glycols - pharmacology</subject><subject>Recombinant Proteins</subject><subject>Retrospective Studies</subject><subject>Ribavirin - pharmacology</subject><subject>Risk Factors</subject><subject>Sex Factors</subject><subject>Surgical Oncology</subject><subject>Viral Load</subject><subject>Viral Nonstructural Proteins - genetics</subject><subject>Young Adult</subject><issn>0944-1174</issn><issn>1435-5922</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kc2OFCEUhYnROO3oA7hR4sJdKRRQP-4mHX8zUZNx1uQ2XHqYVBUlUJPpV_CppVOdTOLCBSE5fOdw4RDykrN3nLH2fWJMCVUx1pfVtdX9I7Lhsiiqr-vHZMN6KSvOW3lGnqV0yxgXTHVPyRnvFW-Zajfkz8-I1pvs75DewbBgosFRGP0UKBhvacLfC05m1fMNUhMiUpgs_X6lLmjEvQ9Ton4qWknxEYYjFmE-UBcivcEZss8-0e0HCvQbzDBhQjouQ_aVwSljpCkv9vCcPHEwJHxx2s_J9aePv7Zfqssfn79uLy4ro6TMVWOc4KIG5hClkSCafrdTxoIwaGXfNY2ru51itmNoFRppuQMrQDjZM8F6cU7errlzDOVtKevRJ4PDUAYLS9I1Z50sZAHf_APehiVOZbbCtLx8sqwLxFfIxJBSRKfn6EeIB82ZPrak15Z0aUkfW9L3xfPqFLzsRrQPjlMtBahXIJWjaY_x4eb_pb5eTQ6Chn30SV9f1cfOedPxpm_FXyYvqCU</recordid><startdate>20090901</startdate><enddate>20090901</enddate><creator>Okanoue, Takeshi</creator><creator>Itoh, Yoshito</creator><creator>Hashimoto, Hiroaki</creator><creator>Yasui, Kohichiroh</creator><creator>Minami, Masahito</creator><creator>Takehara, Tetsuo</creator><creator>Tanaka, Eiji</creator><creator>Onji, Morikazu</creator><creator>Toyota, Joji</creator><creator>Chayama, Kazuaki</creator><creator>Yoshioka, Kentaro</creator><creator>Izumi, Namiki</creator><creator>Akuta, Norio</creator><creator>Kumada, Hiromitsu</creator><general>Japan : Springer Japan</general><general>Springer Japan</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20090901</creationdate><title>Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study</title><author>Okanoue, Takeshi ; Itoh, Yoshito ; Hashimoto, Hiroaki ; Yasui, Kohichiroh ; Minami, Masahito ; Takehara, Tetsuo ; Tanaka, Eiji ; Onji, Morikazu ; Toyota, Joji ; Chayama, Kazuaki ; Yoshioka, Kentaro ; Izumi, Namiki ; Akuta, Norio ; Kumada, Hiromitsu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c544t-6cf3132a0fee4c4a369bb5cda3ced49866f28b50d80ed5ec4d1fad3a3f4903093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Abdominal Surgery</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Amino Acid Sequence</topic><topic>Amino Acid Substitution</topic><topic>Antiviral Agents - pharmacology</topic><topic>Biliary Tract</topic><topic>Colorectal Surgery</topic><topic>Drug Resistance, Viral</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Gastroenterology</topic><topic>Genotype</topic><topic>Hepacivirus - drug effects</topic><topic>Hepacivirus - genetics</topic><topic>Hepatitis C virus</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Hepatitis C, Chronic - genetics</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Interferon alpha-2</topic><topic>Interferon-alpha - pharmacology</topic><topic>Japan</topic><topic>Male</topic><topic>Medication Adherence</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Mutation</topic><topic>Original Article—Liver</topic><topic>Pancreas</topic><topic>Polyethylene Glycols - pharmacology</topic><topic>Recombinant Proteins</topic><topic>Retrospective Studies</topic><topic>Ribavirin - pharmacology</topic><topic>Risk Factors</topic><topic>Sex Factors</topic><topic>Surgical Oncology</topic><topic>Viral Load</topic><topic>Viral Nonstructural Proteins - genetics</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Okanoue, Takeshi</creatorcontrib><creatorcontrib>Itoh, Yoshito</creatorcontrib><creatorcontrib>Hashimoto, Hiroaki</creatorcontrib><creatorcontrib>Yasui, Kohichiroh</creatorcontrib><creatorcontrib>Minami, Masahito</creatorcontrib><creatorcontrib>Takehara, Tetsuo</creatorcontrib><creatorcontrib>Tanaka, Eiji</creatorcontrib><creatorcontrib>Onji, Morikazu</creatorcontrib><creatorcontrib>Toyota, Joji</creatorcontrib><creatorcontrib>Chayama, Kazuaki</creatorcontrib><creatorcontrib>Yoshioka, Kentaro</creatorcontrib><creatorcontrib>Izumi, Namiki</creatorcontrib><creatorcontrib>Akuta, Norio</creatorcontrib><creatorcontrib>Kumada, Hiromitsu</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Family Health Database (Proquest)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okanoue, Takeshi</au><au>Itoh, Yoshito</au><au>Hashimoto, Hiroaki</au><au>Yasui, Kohichiroh</au><au>Minami, Masahito</au><au>Takehara, Tetsuo</au><au>Tanaka, Eiji</au><au>Onji, Morikazu</au><au>Toyota, Joji</au><au>Chayama, Kazuaki</au><au>Yoshioka, Kentaro</au><au>Izumi, Namiki</au><au>Akuta, Norio</au><au>Kumada, Hiromitsu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study</atitle><jtitle>Journal of gastroenterology</jtitle><stitle>J Gastroenterol</stitle><addtitle>J Gastroenterol</addtitle><date>2009-09-01</date><risdate>2009</risdate><volume>44</volume><issue>9</issue><spage>952</spage><epage>963</epage><pages>952-963</pages><issn>0944-1174</issn><eissn>1435-5922</eissn><abstract>Background Chronic hepatitis C (CHC) genotype 1b patients with high viral load are resistant to peginterferon (PEG-IFN) and ribavirin (RBV) combination therapy, especially older and female patients. Methods To elucidate the factors affecting early and sustained viral responses (EVR and SVR), 409 genotype 1b patients CHC with high viral loads who had received 48 weeks of PEG-IFN/RBV therapy were enrolled. The amino acid (aa) sequences of the HCV core at positions 70 and 91 and of the interferon sensitivity determining region (ISDR) were analyzed. Host factors, viral factors, and treatment-related factors were subjected to multivariate analysis. Results Male gender, low HCV RNA load, high platelet count, two or more aa mutations of ISDR, and wild type of core aa 70 were independent predictive factors for SVR. In patients with over 80% adherences to both PEG-IFN and RBV, male gender, mild fibrosis stage, and wild type of core aa 70 were independent predictors for SVR. Conclusions Independent predictive factors for SVR were: no aa substitution at core aa 70, two or more aa mutations in the ISDR, low viral load, high values of platelet count, mild liver fibrosis and male gender.</abstract><cop>Japan</cop><pub>Japan : Springer Japan</pub><pmid>19517057</pmid><doi>10.1007/s00535-009-0087-x</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0944-1174
ispartof Journal of gastroenterology, 2009-09, Vol.44 (9), p.952-963
issn 0944-1174
1435-5922
language eng
recordid cdi_proquest_miscellaneous_21084030
source Springer Nature
subjects Abdominal Surgery
Adolescent
Adult
Aged
Amino Acid Sequence
Amino Acid Substitution
Antiviral Agents - pharmacology
Biliary Tract
Colorectal Surgery
Drug Resistance, Viral
Drug Therapy, Combination
Female
Gastroenterology
Genotype
Hepacivirus - drug effects
Hepacivirus - genetics
Hepatitis C virus
Hepatitis C, Chronic - drug therapy
Hepatitis C, Chronic - genetics
Hepatology
Humans
Interferon alpha-2
Interferon-alpha - pharmacology
Japan
Male
Medication Adherence
Medicine
Medicine & Public Health
Middle Aged
Multivariate Analysis
Mutation
Original Article—Liver
Pancreas
Polyethylene Glycols - pharmacology
Recombinant Proteins
Retrospective Studies
Ribavirin - pharmacology
Risk Factors
Sex Factors
Surgical Oncology
Viral Load
Viral Nonstructural Proteins - genetics
Young Adult
title Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A45%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictive%20values%20of%20amino%20acid%20sequences%20of%20the%20core%20and%20NS5A%20regions%20in%20antiviral%20therapy%20for%20hepatitis%20C:%20a%20Japanese%20multi-center%20study&rft.jtitle=Journal%20of%20gastroenterology&rft.au=Okanoue,%20Takeshi&rft.date=2009-09-01&rft.volume=44&rft.issue=9&rft.spage=952&rft.epage=963&rft.pages=952-963&rft.issn=0944-1174&rft.eissn=1435-5922&rft_id=info:doi/10.1007/s00535-009-0087-x&rft_dat=%3Cproquest_cross%3E1862216151%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c544t-6cf3132a0fee4c4a369bb5cda3ced49866f28b50d80ed5ec4d1fad3a3f4903093%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=217159242&rft_id=info:pmid/19517057&rfr_iscdi=true